17 F. Supp. 3d 1275
N.D. Ga.2014Background
- Plaintiff alleged her implanted Eon Mini Model 3788 spinal cord stimulator (IPG) failed ~6 months post-implant due to a cracked battery weld, requiring surgical removal and resulting injuries and costs.
- Defendant obtained PMA supplemental approval (No. S023) for the Model 3788 by bridging data from earlier Genesis PMA filings and submitted mathematical model projections for battery longevity rather than long-term real-world testing.
- Plaintiff sued under Georgia law asserting breach of express warranty, negligent manufacture and failure to warn, strict liability, and fraud/material misrepresentation; she later withdrew implied warranty and UDTPA claims.
- The court previously allowed limited discovery into PMA specifications and directed Plaintiff to plead specific PMA violations for a parallel-claim theory to avoid MDA preemption.
- Court evaluated whether Plaintiff’s claims are preempted by federal law (21 U.S.C. § 360k) and whether any surviving state-law claims qualify as “parallel” (i.e., premised on violations of particular FDA/PMA requirements) sufficient to avoid preemption.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether breach of express warranty claim survives | Limited Warranty and oral repr. created privity and warranted ~10‑year battery; surgical removal qualifies as consequential damages | No privity; warranty cured defect by replacement so no recoverable damages | Denied dismissal — express warranty survives (privity and damages adequately pled) |
| Whether negligent manufacture / design claims are preempted | Battery weld defect and FDA recalls/inspections show CGMP/PMA violations (parallel claim) | Preempted by MDA; CGMPs are generic and not device‑specific PMA requirements | Negligent manufacture claim survives as a parallel claim tied to recalls/CGMP violations; strict liability claim is preempted and dismissed |
| Whether alleged 10‑year battery life is an FDA‑required performance standard | FDA approval required 10‑year minimum life; failure to meet it violates PMA | No formal FDA performance standard was promulgated; approval relied on manufacturer representations and data, not rulemaking | Claim premised on an implied 10‑year federal performance standard fails (no such standard) |
| Whether negligent failure to warn via late MDR filings plausibly caused injury | Defendant failed to timely file MDRs/adverse event reports; had they been filed Plaintiff/physicians would have known and avoided implant | MDR disclosures are discretionary; no plausible link that MDRs would have been public, reached Plaintiff/physician, and prevented injury | Dismissed — causation not plausibly alleged for failure‑to‑report theory |
| Whether fraud/material misrepresentation claim meets Rule 9(b) and causation/justifiable reliance | Defendant marketed "guaranteed to last 10 years" and concealed adverse events causing Plaintiff to rely and be harmed | Statements not pleaded with particularity; omissions/warnings regulated by FDA and preempted | Dismissed — fraud insufficiently particular and omissions-based theory preempted |
Key Cases Cited
- Riegel v. Medtronic, Inc., 552 U.S. 312 (holding PMA process creates federal requirements and state claims that impose different or additional requirements are preempted)
- Wolicki-Gables v. Arrow Int’l, Inc., 634 F.3d 1296 (11th Cir.) (explaining requirements for pleading a "parallel" claim: identify particular federal regulation/PMA requirement and show causal link to injury)
- Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard: allegations must state a plausible claim for relief)
- Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (pleading must contain enough factual matter to state a plausible claim)
- Buckman Co. v. Plaintiffs’ Legal Comm., 531 U.S. 341 (private-party claims that are really attempts to enforce the FDA’s regulatory regime are preempted/impliedly precluded)
- Hughes v. Boston Scientific Corp., 631 F.3d 762 (5th Cir.) (illustrative causation theory for failure‑to‑report claims where extensive underreporting could have altered physician/patient decisions)